In the News | Friends of Cancer Research

You are here

In the News

November 25, 2019
Tumor mutational burden (TMB) has generated interest as a potential biomarker of response to immunotherapy and has already been examined in the context of several lung cancer trials to gauge its... Read more
November 25, 2019
Friends of Cancer Research (Friends) recently announced the launch of its latest project, ctMoniTR. This pilot project will aim to harmonize the use of circulating tumor DNA (ctDNA) to monitor... Read more
November 25, 2019
On November 20, 2019, Stephen Hahn, MD, President Trump’s nominee to be the next Commissioner of the U.S. Food and Drug Administration (FDA), appeared before the Senate Health, Education, Labor, and... Read more
November 20, 2019
Washington, DC – November 20, 2019 – Today, Dr. Stephen Hahn, President Trump’s nominee to be the next Commissioner of the U.S. Food and Drug Administration (FDA), appeared before the Senate Health,... Read more
November 12, 2019
New Project Aims to Harmonize ctDNA for Monitoring Treatment Response   Washington, DC – November 12, 2019 – Today, Friends of Cancer Research (Friends) announced the launch of its latest project,... Read more
November 12, 2019
The US Food and Drug Administration (FDA) may expand a pilot project that allows for simultaneous drug approval decisions from US, Canadian and Australian regulators to include Singapore and... Read more
October 30, 2019
The number of expedited FDA approvals for cancer drugs that are based on surrogate end points is increasing, leading many to search for new ways to uncover efficacy and safety data to justify the... Read more
October 30, 2019
Sudip Parikh has helped shape U.S. science policy as a staffer on a powerful congressional spending panel. He’s been a senior health care executive for a large nonprofit organization that manages... Read more
October 25, 2019
On September 24, 2019, Friends of Cancer Research (Friends) hosted its 23rd Annual Cancer Leadership Awards Reception. The event honored individuals who have been champions of cancer research and... Read more

Pages